Indefinite Delivery Contract SPE2DU25D9341

The federal contract IDV award is a $4,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract provides a single-award IDC vehicle for the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.

This IDC is part of the DLA Troop Support Medical Supply Chain's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The solicitation for this program is expected to be issued in March 2024 with an estimated total value of $30.3 billion across all regions and contract periods. The contract will have a 30-month base period and three 30-month option periods, and will be awarded using a Lowest Price Technically Acceptable (LPTA) evaluation methodology.